Systems and methods for controlling neurostimulation of acupuncture sites using an implantable cardiac rhythm management device
First Claim
Patent Images
1. A method for use with an implantable medical system for implant within a patient where the implantable medical system is equipped for neurostimulation, the system comprising:
- detecting, with the implantable medical system, a parameter representative of one of more of;
heart failure;
arrhythmia;
atrial tachycardia/atrial fibrillation (AT/AF) burden;
hypertension;
Cheyne-Stokes respiration (CSR) sleep apnea;
cardiac ischemia; and
angina; and
in response to the detected parameter, delivering neurostimulation, via the implantable medical system, to one or more acupuncture sites within anterior regions of one or more of the neck, thorax and abdomen of the patient;
wherein if the detected parameter includes parameters representative of hypertension, the acupuncture sites for delivery of the neurostimulation includes one or more of acupuncture sites P1 and P2;
and further wherein if the detected parameter includes parameters representative of at least one of CSR and sleep apnea, the acupunctures sites for delivery of the neurostimulation includes one or more of acupuncture sites L1 and L2.
1 Assignment
0 Petitions
Accused Products
Abstract
Techniques are provided for use with an implantable cardiac rhythm management (CRMD) system equipped to deliver neurostimulation to acupuncture sites within anterior regions of the neck, thorax or abdomen of the patient. Parameters associated with the health of the patient are detected, such as parameters indicative of arrhythmia, heart failure and hypertension.
-
Citations
26 Claims
-
1. A method for use with an implantable medical system for implant within a patient where the implantable medical system is equipped for neurostimulation, the system comprising:
-
detecting, with the implantable medical system, a parameter representative of one of more of;
heart failure;
arrhythmia;
atrial tachycardia/atrial fibrillation (AT/AF) burden;
hypertension;
Cheyne-Stokes respiration (CSR) sleep apnea;
cardiac ischemia; and
angina; andin response to the detected parameter, delivering neurostimulation, via the implantable medical system, to one or more acupuncture sites within anterior regions of one or more of the neck, thorax and abdomen of the patient; wherein if the detected parameter includes parameters representative of hypertension, the acupuncture sites for delivery of the neurostimulation includes one or more of acupuncture sites P1 and P2; and further wherein if the detected parameter includes parameters representative of at least one of CSR and sleep apnea, the acupunctures sites for delivery of the neurostimulation includes one or more of acupuncture sites L1 and L2. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20)
-
-
21. An implantable medical system for implant within a patient, the system comprising:
-
a neurostimulation lead system configured to deliver neurostimulation to one or more acupuncture sites within an anterior region of one or more of the neck, thorax and abdomen of the patient, the neurostimulation lead system including a percutaneous lead having three pairs of bipolar electrodes, with each pair at a different site; a health parameter detection system operative to detect parameters representative of at least one of heart failure, arrhythmia, hypertension, diabetes and cardiac ischemia of the patient; and a neurostimulation controller, operative in response to the detected parameter of the patient, to deliver neurostimulation to the one or more acupuncture sites using the neurostimulation lead system. - View Dependent Claims (22, 23, 24, 25, 26)
-
Specification